Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
mRNA | BIRB 0796 | GDSC1000 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.0049 | 0.9 |
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.018 | 0.9 |
mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |